HSCS Q4 EPS Raised by Ascendiant Capital Markets

Heart Test Laboratories, Inc. (NASDAQ:HSCSFree Report) – Research analysts at Ascendiant Capital Markets upped their Q4 2025 EPS estimates for shares of Heart Test Laboratories in a report issued on Tuesday, March 18th. Ascendiant Capital Markets analyst L. Ward now forecasts that the company will post earnings of ($2.51) per share for the quarter, up from their previous estimate of ($2.57). Ascendiant Capital Markets has a “Buy” rating and a $14.00 price target on the stock. The consensus estimate for Heart Test Laboratories’ current full-year earnings is ($10.01) per share. Ascendiant Capital Markets also issued estimates for Heart Test Laboratories’ Q1 2026 earnings at ($2.41) EPS, Q2 2026 earnings at ($2.46) EPS, Q3 2026 earnings at ($2.49) EPS, Q4 2026 earnings at ($2.42) EPS and FY2026 earnings at ($9.78) EPS.

Heart Test Laboratories (NASDAQ:HSCSGet Free Report) last released its quarterly earnings results on Thursday, March 13th. The company reported ($2.57) earnings per share for the quarter, missing the consensus estimate of ($2.53) by ($0.04).

Separately, Maxim Group reissued a “buy” rating and issued a $12.00 price objective on shares of Heart Test Laboratories in a research note on Wednesday, December 18th.

Read Our Latest Stock Analysis on Heart Test Laboratories

Heart Test Laboratories Stock Performance

NASDAQ HSCS opened at $2.93 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.72 and a quick ratio of 1.52. The stock’s 50 day simple moving average is $3.40 and its 200-day simple moving average is $3.42. The company has a market cap of $2.87 million, a PE ratio of -0.37 and a beta of 2.77. Heart Test Laboratories has a 1-year low of $2.36 and a 1-year high of $13.50.

Heart Test Laboratories Company Profile

(Get Free Report)

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.

Featured Stories

Earnings History and Estimates for Heart Test Laboratories (NASDAQ:HSCS)

Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.